Marc Berthiaume

Known as Covifenz, the vaccine was developed by Medicago, a biotechnology company based in Quebec City that uses a plant host to make virus−like particles which help the body’s immune system make antibodies.  

With new and more contagious variants of COVID-19 escalating in Canada, provincial governments lifting lockdown restrictions must be ready to slam them back into place at a moment's notice, Canada's chief public health doctor said on Tuesday, February 9, 2021.